Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: Nationwide inpatient sample 2000-2009

Journal of Arthroplasty

Volumn 29, Issue 11, 2014, Pages 2070-2077

  Klika, Alison K ^a   Small, Travis J ^a   Saleh, Anas ^a   Szubski, Caleb R ^a   Chandran Pillai, Aiswarya Lekshmi Pillai ^b   Barsoum, Wael K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood loss; Complications; Nationwide inpatient sample; Total knee arthroplasty; Transfusion

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; RISK FACTOR; TOTAL KNEE REPLACEMENT; ADVERSE EFFECTS; CROSS-SECTIONAL STUDY; ECONOMICS; EPIDEMIOLOGY; FACTUAL DATABASE; HOSPITAL MORTALITY; HOSPITALIZATION; KNEE REPLACEMENT; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT DISCHARGE; UNITED STATES;

EID: 84908281935     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2014.06.018     Document Type: Article

References (28)

1. Sehat K.R., Evans R.L., Newman J.H. Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg (Br) 2004, 86(4):561.
2. Bierbaum B.E., Callaghan J.J., Galante J.O., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 81(1):2.
3. Bong M.R., Patel V., Chang E., et al. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty 2004, 19(3):281.
4. Rosencher N., Kerkkamp H.E., Macheras G., et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003, 43(4):459.
5. Surgenor D.M., Wallace E.L., Hao S.H., et al. Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med 1990, 322(23):1646.
6. Wallace E.L., Churchill W.H., Surgenor D.M., et al. Collection and transfusion of blood and blood components in the United States, 1994. Transfusion 1998, 38(7):625.
7. Sullivan M.T., Cotten R., Read E.J., et al. Blood collection and transfusion in the United States in 2001. Transfusion 2007, 47(3):385.
8. Wallace E.L., Churchill W.H., Surgenor D.M., et al. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995, 35(10):802.
9. Schreiber G.B., Busch M.P., Kleinman S.H., et al. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996, 334(26):1685.
10. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990, 30(7):583.
11. Linden J.V., Tourault M.A., Scribner C.L. Decrease in frequency of transfusion fatalities. Transfusion 1997, 37(2):243.
12. Ness P.M., Shirey R.S., Thoman S.K., et al. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion 1990, 30(8):688.
13. Shulman I.A. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch. Arch Pathol Lab Med 1990, 114(4):412.
14. Popovsky M.A., Moore S.B. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985, 25(6):573.
15. Madjdpour C., Spahn D.R. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 2005, 95(1):33.
16. Healy W.L., Rana A.J., Iorio R. Hospital economics of primary total knee arthroplasty at a teaching hospital. Clin Orthop Relat Res 2011, 469(1):87.
17. Quality AfHRa HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project. 2000-2009 2013, [www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed January 1, 2013].
18. Blanchette C.M., Joshi A.V., Szpalski M., et al. Burden of blood transfusion in knee and hip surgery in the US and Belgium. J Med Econ 2009, 12(3):171.
19. Memtsoudis S.G., Ma Y., Gonzalez Della Valle A., et al. Perioperative outcomes after unilateral and bilateral total knee arthroplasty. Anesthesiology 2009, 111(6):1206.
20. Segal J.B., Guallar E., Powe N.R. Autologous blood transfusion in the United States: clinical and nonclinical determinants of use. Transfusion 2001, 41(12):1539.
21. Noticewala M.S., Nyce J.D., Wang W., et al. Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplasty 2012, 27(6):961.
22. Spahn D.R. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010, 113(2):482.
23. Murphy G.J., Reeves B.C., Rogers C.A., et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007, 116(22):2544.
24. Pedersen A.B., Mehnert F., Overgaard S., et al. Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study. BMC Musculoskelet Disord 2009, 10:167.
25. Watts C.D., Pagnano M.W. Minimising blood loss and transfusion in contemporary hip and knee arthroplasty. J Bone Joint Surg (Br) 2012, 94(11 Suppl A):8.
26. Report C. MedPAR database based on ICD-9-CM codes for 100% of Medicare beneficiaries 2008, [Data on file].
27. Etchason J., Petz L., Keeler E., et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995, 332(11):719.
28. Namba R.S., Inacio M.C., Paxton E.W. Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees. J Bone Joint Surg Am 2013, 95(9):775.